Raidium, a Paris and Silicon Valley-based radiology startup, has launched its AI-native imaging platform in the US at Moffitt Cancer Center, one of the country’s leading oncology research institutions. The platform, called Raidium Read, replaced Moffitt’s legacy radiomics applications and is currently available for clinical trials and research use. FDA 510(k) clearance is expected before […] This story continues at The Next Web